RECURSION PHARMACEUTICALS INC. - CLASS A COMMON S

Recursion to Participate in Upcoming Investor Conference

02 11 2023 07:05:00 提供 Nasdaq GlobeNewswire

Recursion to Participate in Upcoming Investor Conferences

05 9 2023 15:30:00 提供 Nasdaq GlobeNewswire

Recursion Announces Completion of Phase 1 Study for REC-3964 for Clostridioides Difficile Infection

05 9 2023 06:59:00 提供 Nasdaq GlobeNewswire

Recursion Bridges the Protein and Chemical Space with Massive Protein-Ligand Interaction Predictions Spanning 36 Billion Compounds

08 8 2023 07:00:01 提供 Nasdaq GlobeNewswire

Recursion Provides Business Updates and Reports Second Quarter 2023 Financial Results

08 8 2023 06:58:00 提供 Nasdaq GlobeNewswire

Recursion to Participate in Upcoming Investor Conference

01 8 2023 07:30:00 提供 Nasdaq GlobeNewswire

Recursion Launches Valence Labs at ICML with a Commitment to Open Science Including $1 Million in Academic Scholarships

26 7 2023 17:58:00 提供 Nasdaq GlobeNewswire

Recursion Announces Collaboration and $50 Million Investment from NVIDIA to Accelerate Groundbreaking Foundation Models in AI-Enabled Drug Discovery

12 7 2023 07:30:00 提供 Nasdaq GlobeNewswire

Recursion Celebrates Opening of Its Canadian Headquarters in Toronto with Government Officials and the Biotech Ecosystem

26 6 2023 10:48:04 提供 Nasdaq GlobeNewswire

Recursion’s Phase 2 Trial for the Treatment of Cerebral Cavernous Malformation has Fully Enrolled

13 6 2023 07:00:01 提供 Nasdaq GlobeNewswire

Recursion to Participate in Upcoming Investor Conferences

01 6 2023 07:30:00 提供 Nasdaq GlobeNewswire

Altitude Lab Relocates to Gateway’s BioHive Hub

25 5 2023 15:00:00 提供 Nasdaq GlobeNewswire

Recursion Provides Business Updates and Reports First Quarter 2023 Financial Results

08 5 2023 07:14:39 提供 Nasdaq GlobeNewswire

Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilities

08 5 2023 06:59:00 提供 Nasdaq GlobeNewswire